Current Primary Outcome Measures •Numeric Rating Scale at 60 days and 90 days post procedure (lead removal) [ Time Frame: at 60 days (plus or minus 5 days) and 90 days (plus or minus 10 days) ] ...
Please provide your email address to receive an email when new articles are posted on . Patients used the device for 60 days, and effects persisted for 6 months. 71% of patients reported improved Neck ...
SPR will feature eight abstracts on 60-day peripheral nerve stimulation (PNS) with SPRINT ® PNS that will be presented at the ...
CARLSBAD, Calif.--(BUSINESS WIRE)--Nalu Medical, Inc. (“Nalu”) a Carlsbad, California-based company that markets a minimally invasive neurostimulation implant for the management of chronic intractable ...
Pendergrast is an anesthesiology resident physician at the University of Michigan. The 1 in 5 Americans suffering from chronic pain may soon lose access to evidence-based interventions that have ...
CARLSBAD, Calif.--(BUSINESS WIRE)--Nalu Medical Inc. (“Nalu”) revealed significant findings from a landmark clinical trial evaluating the Nalu Peripheral Nerve Stimulation (PNS) System utilizing their ...
The US Food and Drug Administration (FDA) has granted 510 (k) clearance for BlueWind Medical, Ltd.’s enhanced Revi® implantable tibial neuromodulator for treatment of urgency urinary incontinence (UUI ...
Please provide your email address to receive an email when new articles are posted on . Multiple Medicare Administrative Contractors have proposed to restrict coverage for peripheral nerve block ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results